FDA 503B outsourcing facilities in Wisconsin
Wisconsin has 1 FDA-registered 503B outsourcing facility in the PeptideGrids directory, none with FDA drug recalls on record, the earliest registered in 2022. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| Bennett Pharmaceuticals of America LLC | Hudson | 2022 | None on record |
503B compounding in Wisconsin
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Wisconsin must hold the appropriate state pharmacy license. Verify any facility's current license with the Wisconsin Pharmacy Examining Board.
Compounded peptides and GLP-1s
503B facilities are a primary supply route for compounded peptides and GLP-1s, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the full GLP-1 and therapeutic peptide databases, or the national directory.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Wisconsin?
1 FDA-registered 503B outsourcing facility is listed in Wisconsin on PeptideGrids, the earliest registered in 2022.
Which Wisconsin 503B facilities have FDA recalls on record?
None of the Wisconsin facilities in our directory have FDA drug recalls on record.
How do I verify a pharmacy license in Wisconsin?
Use the Wisconsin Pharmacy Examining Board license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.